Technologies Enabling Nuclear Medicine Imaging
Redefining the Boundaries of Standard Medical Imaging through Nuclear Medicine
23-May-2018
Global
Technology Research
D7EF-01-00-00-00
HC03012-GL-TR_21933
Tech Vision's latest research service from medical imaging technology cluster highlights the innovations and emerging technology trends in the domain of nuclear imaging. Nuclear imaging is evolving as a next frontier in the medical imaging industry. Nuclear imaging gained significant importance in medical industry space by understanding physiology of disease that helps in adressing the disease at early stages with faster and accurate diagnosis.
There is an increased adoption of nuclear imaging due to the developments of novel radiopharmaceuticals in new clinical areas like orthopaedicas and neurology when compared to traditionally used clinical areas like oncology and cardiology. However, the nuclear imaging inductry poised to face challenges like decreased federal support, heavy regulatory requirements, inadequate supply of radionuclides for research, etc. This report is key for strategies that can be employed the market participants to addess the industry challenges. The analysis would be key for the new entrants and established market players to create viable and implementable strategies to ensure continued innovations and stay competitive in nuclear imaging industry.
This research service sheds light on nuclear imaging technology landcape, key growth opportunities for research and development, associated regulatory and technology challenges and their corresponding recommendations, key company profiling, and intellectual property landscape.
1.1 Scope of Research
1.2 Research Methodology
1.2 Research Methodology (continued)
2.1 Nuclear Medicine is Key to Understand Biochemical Functioning of Human Organs
2.2 Nuclear Medical Imaging and its Brief overview
2.3 Historical Perspective of Nuclear Medicine Imaging
2.4 Nuclear Medicine Imaging Segmentation
2.5 Nuclear Medicine Segmentation Based on Image Applications
2.6 Radiopharmaceuticals Form the Integral Part of Nuclear Medicine
2.6.1 Radiopharmaceuticals Segmentation Used in Infection Scintigraphy
2.6.2 Clinically Used Radiopharmaceuticals and Radionuclides
2.7 Gamma Camera in Nuclear Imaging
2.8 Single photon emission computer tomography (SPECT) in nuclear imaging
2.9 Positron Emission Tomography (PET) in Nuclear Imaging
2.10 Software for Quantification of Nuclear Medicine Imaging Data
3.1 Market and Technology Drivers Ranked in Order of Impact (Global), 2018-2024
3.1.1 Adoption of Multimodality Imaging helped in Exploring Novel Therapeutic Areas
3.1.2 Development in Informatics solutions eased the Imaging Analysis
3.1.3 Nuclear Medicine Imaging facilitated more research into Neurodegenerative Diseases
3.1.4 Development of Novel Radiopharmaceuticals helps in Targeting Unaddressed Therapeutic Areas
3.2 Market and Technology Restraints Ranked in Order of Impact (Global), 2018-2024
3.2.1 High Cost of Nuclear Imaging Modalities Making it Difficult to Reach Remote Areas Across the World
3.2.2 Reduced Research Funding on Imaging Equipment and Novel Radiopharmaceuticals hampering the growth
3.2.3 Time Consuming and Less Technology transfer from Laboratory to Commercial Market space
4.1 Company Innovation Profiling of Philips Healthcare
4.2 Company Innovation Profiling of General Electric
4.3 Company Innovation Profiling of Siemens Healthineers
5.1 Customizing the Technology Based on Patients’ Needs
5.2 Assessing the Efficacy and Biochemical Functioning of New Drugs
5.3 Faster Diagnosis and Increased Availability of Nuclear Medicine
6.1 Improving Functionalities will Help Expand Imaging Applications
6.2 Combining Imaging Modalities to Create Multi-modal Scanners
6.3 Need for Innovations in Small Animal Imaging
6.4 Need for Development of Novel Radiotracers
7.1 Federal and Regulatory Challenges in Nuclear Medicine Imaging
7.2 Shortage of Medical Radionuclides and Trained Nuclear Medicine Scientists
8.1 Nuclear Medicine Imaging – Regional IP Analysis
8.2 Nuclear Medicine Imaging – By Top Assignees
8.3 The US is an Attractive Market and Tops the Chart in Terms of the Number of Technology Innovations Originated
8.4 Patent filings related to Image Reconstruction using Nuclear Medicine
8.5 Patent filing in Operational Methods and Attenuation Compensation in Nuclear Medicine Imaging
8.6 Patents related to Performance Enhancement in Nuclear Medicine Imaging
8.7 Key Patents related to PET Advancements and NM Imaging of Neurodegenerative Diseases
9.1 Database of Key Industry Participants
9.2 Database of Key Industry Participants and References
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.